[1] 叶爱琴,吕建峰,刘 华.草酸铂致肝损伤的临床观察[J].肿瘤防治研究,2007,34(10):783-784.
[2] 孙 燕,周际昌.临床肿瘤内科手册[M].4版.北京:人民卫生出版社,2004:102.
[3] Slade JH, Alattar ML, Fogelman DR, et al. Portal hypertension associated with oxaliplatin administration: clinical manifestations of hepatic sinusoidal injury[J].Clin Colorectal Cancer,2009,8(4): 225-230.
[4] Overman MJ, Maru DM, Charnsangavej C, et al. Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury[J].J Clin Oncol,2010,28(15): 2549-2555.
[5] Motoori S, Kawase T, Nishimura H, et al. Two cases of advanced colorectal cancer which demonstrated the reversibility of oxaliplatin-mediated increase in splenic volume[J].Gan To Kagaku Ryoho,2011,38(4): 677-680.
[6] 陈玉强,洪节约,张雅雅,等.异甘草酸镁治疗肝癌动脉栓塞化疗肝损伤的临床研究[J].实用临床医药杂志,2010,14(17):15-17.
[7] Mao YM,Zeng MD,Chen Y.Magnesium isoglycyrrhizinate in the treatment of chronic liver diseases:a randomized,doubleblind,multi-doses,active drug controlled,multi-center study[J].Zhonghua Gan Zang Bing Za Zhi,2009,17:847-851.
[8] 赵艳娟,杨梓梅.异甘草酸镁治疗慢性重型乙型肝炎的临床疗效观察[J].临床肝胆病杂志,2010,26(5):524-526.
[9] 董大勇.异甘草酸镁治疗慢性乙型肝炎的临床观察.实用临床医药杂志,2010,14(19):36-37.